Archive | July, 2002

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Leading the way in experimental and clinical research in hematology July 15, 2002; Blood: 100 (2) Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Robert J. McKallip, Catherine Lombard, Michael Fisher, Billy R. Martin, Seongho Ryu, Steven Grant, Prakash S. Nagarkatti, and Mitzi Nagarkatti Author Affiliations Article Figures & Data […]